Progyny to Showcase Menopause Care Outcomes at 2026 Annual Meeting
Event summary
- Progyny will present new research on menopause care outcomes at The Menopause Society 2026 Annual Meeting in San Diego, October 20–24, 2026.
- The study, conducted with Morehouse School of Medicine, evaluates symptom improvement in Progyny’s employer-sponsored Menopause and Midlife program.
- Gloria Richard-Davis, MD, MBA, will present findings during Concurrent Session #2 on October 22.
- Progyny aims to expand access to evidence-based menopause care through employer-sponsored programs.
The big picture
Progyny’s focus on menopause care aligns with broader industry trends toward comprehensive women’s health solutions, extending beyond fertility into midlife health. The company’s employer-sponsored model positions it to capitalize on increasing demand for integrated healthcare benefits as workforce demographics shift. Success in scaling this program could further solidify Progyny’s leadership in the women’s health benefits space.
What we're watching
- Program Scalability
- Whether Progyny can sustain real-world symptom improvement as it scales its menopause care model across more employers.
- Market Differentiation
- How the research findings position Progyny against competitors in the growing women’s health benefits space.
- Regulatory and Employer Trends
- The pace at which employer demand for menopause care solutions grows, driven by workforce demographics and healthcare policy shifts.